ライフサイエンスコーパス: coronary artery bypass

1 tasectomies or biopsy (4%), and simultaneous coronary artery bypass (11%).

2 naturally existing internal mammary (IMA)-to-coronary artery bypasses and their quantitative effect o

3 ed discharge data for patients who underwent coronary artery bypass (CABG), hip replacement, and knee

4 Cardiac surgery, including coronary artery bypass, cardiac valve, and aortic proced

5 In the APTITUDE-Coronary Artery Bypass Graft (APTITUDE-CABG) study, vaso

6 ed to compare the long-term effectiveness of coronary artery bypass graft (CABG) and percutaneous cor

7 ercutaneous coronary intervention (PCI), and coronary artery bypass graft (CABG) are an unintended co

8 PCI) within 2 years and within 5 years after coronary artery bypass graft (CABG) in the absence of ne

9 coronary artery disease (LMCAD) treated with coronary artery bypass graft (CABG) or percutaneous coro

10 cutaneous coronary intervention (PCI) versus coronary artery bypass graft (CABG) routinely exclude pa

11 Racial disparities in mortality rates after coronary artery bypass graft (CABG) surgery are well est

12 e (CAD) had improved long-term outcomes with coronary artery bypass graft (CABG) surgery compared wit

13 orary drug-eluting stent (DES) compared with coronary artery bypass graft (CABG) surgery in patients

14 The effect on post-operative outcomes after coronary artery bypass graft (CABG) surgery is not clear

15 ss of coronary revascularization with either coronary artery bypass graft (CABG) surgery or percutane

16 gnosis and a greater prognostic benefit from coronary artery bypass graft (CABG) surgery than those w

17 recent studies have compared the outcomes of coronary artery bypass graft (CABG) surgery with percuta

18 function and vein graft failure (VGF) after coronary artery bypass graft (CABG) surgery.

19 d improve patients' prognosis after elective coronary artery bypass graft (CABG) surgery.

20 trial, yet it is now a quality standard for coronary artery bypass graft (CABG) surgery.

21 Data are sparse on long-term mortality after coronary artery bypass graft (CABG) surgery.

22 Multiple studies have compared coronary artery bypass graft (CABG) with percutaneous co

23 d with reduced morbidity and mortality after coronary artery bypass graft (CABG).

24 hropometrics) of CR post-HT compared to post-coronary artery bypass graft (CABG).

25 e potential added advantage of multiarterial coronary artery bypass graft (MA-CABG).

26 nce intervals, 1.02-1.03; P<0.001), previous coronary artery bypass graft (OR, 1.44; 95% confidence i

27 ery disease with traditional single-arterial coronary artery bypass graft (SA-CABG) has been associat

28 ive, high-risk cardiac surgery (ie, combined coronary artery bypass graft [CABG] surgery and valve re

29 elines recommend surgical revascularization (coronary artery bypass graft [CABG]) over percutaneous c

30 theterization followed by treatment (ie, 128 coronary artery bypass graft [CABG], 150 percutaneous co

31 There also were >18,000 fewer coronary artery bypass graft admissions in 2012 than in

32 Procedural need for emergent coronary artery bypass graft and mortality rates were lo

33 ariable cost in patients undergoing elective coronary artery bypass graft and valve surgeries.

34 erwent percutaneous coronary intervention or coronary artery bypass graft due to significant stenosis

35 major bleeding and a 6-fold increase in non-coronary artery bypass graft life-threatening bleeding w

36 death, myocardial infarction, stroke, or non-coronary artery bypass graft major bleeding.

37 7% men) were included, with a mean time from coronary artery bypass graft of 12+/-5 years.

38 Among 6497 post- coronary artery bypass graft participants, mean and medi

39 120 coronary artery bypass graft patients aged 45-65 years u

40 on in weaning from mechanical ventilation in coronary artery bypass graft patients.

41 ge, left atrial size, diabetes, and previous coronary artery bypass graft procedure were significantl

42 implantation were more likely to have prior coronary artery bypass graft procedures, higher peak tro

43 in injection into epicardial fat pads during coronary artery bypass graft provided substantial atrial

44 tes (39.2% versus 13.2%; P<0.001) and higher coronary artery bypass graft rates (9.5% versus 4.4%; P<

45 Despite higher PCI and coronary artery bypass graft rates for Medicare patients

46 Hospitals that performed 1 or more coronary artery bypass graft surgeries in a given calend

47 s driven by BARC major bleeding unrelated to coronary artery bypass graft surgery (1.6% vs 2.3%, RR 0

48 nary artery disease (64.4% vs. 83.7%), prior coronary artery bypass graft surgery (19.8% vs. 61.2%),

49 ence of diabetes mellitus (45%) and previous coronary artery bypass graft surgery (34%).

50 Coronary artery bypass graft surgery (CABG) compared wit

51 h (SCD) in patients with heart failure after coronary artery bypass graft surgery (CABG) has not been

52 New-onset atrial fibrillation (AF) after coronary artery bypass graft surgery (CABG) is associate

53 Guidelines recommend coronary artery bypass graft surgery (CABG) over percuta

54 se in Individuals With Diabetes) trial found coronary artery bypass graft surgery (CABG) was associat

55 vessel or left main coronary artery disease, coronary artery bypass graft surgery (CABG) was associat

56 Current guidelines recommend coronary artery bypass graft surgery (CABG) when treatin

57 , 0.61; 95% confidence interval, 0.55-0.67), coronary artery bypass graft surgery (n=1077; hazard rat

58 However, there is paucity of data comparing coronary artery bypass graft surgery against newer gener

59 nd CSCs were isolated from vein leftovers of coronary artery bypass graft surgery and discarded atria

60 among Medicare beneficiaries undergoing any coronary artery bypass graft surgery and higher observed

61 h diabetes mellitus and multivessel disease, coronary artery bypass graft surgery and percutaneous co

62 (with percutaneous coronary intervention or coronary artery bypass graft surgery as appropriate) plu

63 Medicare data to compare change in rates of coronary artery bypass graft surgery between 2002 to 200

64 of a deleterious effect of P4P on access to coronary artery bypass graft surgery for high-risk patie

65 l infarction/cardiogenic shock (n=1705), and coronary artery bypass graft surgery groups.

66 without acute coronary syndromes or previous coronary artery bypass graft surgery in periods before (

67 had diabetes mellitus and underwent isolated coronary artery bypass graft surgery or percutaneous cor

68 oing a coronary revascularization procedure: coronary artery bypass graft surgery or percutaneous cor

69 ntly more complex, both clinically (previous coronary artery bypass graft surgery prevalence, 48% ver

70 Coronary artery bypass graft surgery rates for high-risk

71 Coronary artery bypass graft surgery rates for patients

72 artery (RA) can improve clinical outcomes in coronary artery bypass graft surgery remains unclear.

73 nts with no acute coronary syndrome/no prior coronary artery bypass graft surgery that were rated as

74 nsfection IV) analysis reported that EVH for coronary artery bypass graft surgery was associated with

75 Coronary artery bypass graft surgery was the only signif

76 MIs related to coronary artery bypass graft surgery were few, but numer

77 ysmal atrial fibrillation and indication for coronary artery bypass graft surgery were randomized to

78 Sixty patients undergoing coronary artery bypass graft surgery were randomized to

79 uitable collaterals, no smoking, no previous coronary artery bypass graft surgery, and left anterior

80 Death, myocardial infarction, coronary artery bypass graft surgery, and repeat PCI wer

81 harvesting (EVH) should be standard care in coronary artery bypass graft surgery, but vein quality a

82 L after AMI, including younger age, previous coronary artery bypass graft surgery, depressive symptom

83 al Health Insurance Database associated with coronary artery bypass graft surgery, myocardial infarct

84 ut lower rates of multivessel disease, prior coronary artery bypass graft surgery, prior MI, and smok

85 spital percutaneous coronary intervention or coronary artery bypass graft surgery, respectively.

86 death, angiogram-confirmed angina pectoris, coronary artery bypass graft surgery, stents, and angiop

87 myocardial infarction, coronary angioplasty, coronary artery bypass graft surgery, stroke).

88 who underwent cardiac interventions, such as coronary artery bypass graft surgery, were also included

89 Is; and 19 (1.6%) more sites were performing coronary artery bypass graft surgery.

90 ison with IV propofol for patient undergoing coronary artery bypass graft surgery.

91 onsortium (BARC) major bleeding unrelated to coronary artery bypass graft surgery.

92 risk of death and stroke when compared with coronary artery bypass graft surgery.

93 t greatest short-term risk of mortality with coronary artery bypass graft surgery.

94 isease, 218 (22%) were deemed ineligible for coronary artery bypass graft surgery.

95 onary intervention, or previous multi-vessel coronary artery bypass graft surgery.

96 phically confirmed angina (1.91; 1.59-2.29), coronary artery bypass graft surgery/coronary angioplast

97 mained at higher risk for repeat procedures (coronary artery bypass graft surgery: 10.7% versus 6.8%,

98 for target vessel or target lesion failure (coronary artery bypass graft surgery: 8.9% versus 3.9%,

99 iac rehabilitation (CR) is recommended after coronary artery bypass graft surgery; however, the conse

100 There was a 3-fold increase in all non-coronary artery bypass graft Thrombolysis In Myocardial

101 ive atrial fibrillation within 30 days after coronary artery bypass graft was 2 of 30 patients (7%) i

102 trial that enrolled patients with a previous coronary artery bypass graft who had developed at least

103 ation (percutaneous coronary intervention or coronary artery bypass graft) was performed during index

104 aneurysm repair, $5309.78 (17% increase) for coronary artery bypass graft, and $7813.53 (53% increase

105 farction, unstable and stable angina, recent coronary artery bypass graft, and peripheral arterial di

106 resection, abdominal aortic aneurysm repair, coronary artery bypass graft, aortic valve replacement,

107 1 patients aged 60 years or older undergoing coronary artery bypass graft, aortic valve surgery, mitr

108 underwent abdominal aortic aneurysm repair, coronary artery bypass graft, or colon resection for neo

109 ADBRs included non-coronary artery bypass graft-related Thrombolysis In Myo

110 gulation of miR-1 in the right atrium during coronary artery bypass graft.

111 ove clinical outcomes in patients undergoing coronary-artery bypass graft (CABG) surgery is not known

112 s focused on the use of drug eluting stents, coronary-artery bypass graft surgery and anti-thrombosis

113 ne surgery (9.8%), herniorrhaphy (7.4%), and coronary artery bypass grafting (7.0%).

114 lectomy (189229 patients at 1876 hospitals), coronary artery bypass grafting (CABG) (218940 patients

115 after the procedure between on- and off-pump coronary artery bypass grafting (CABG) (n = 6; low SOE),

116 injury (AKI) is a common complication after coronary artery bypass grafting (CABG) and is associated

117 n with percutaneous coronary intervention or coronary artery bypass grafting (CABG) and its long-term

118 o address the most recent evidence bases for coronary artery bypass grafting (CABG) and stenting in p

119 re, and coronary artery disease suitable for coronary artery bypass grafting (CABG) are at higher ris

120 ved ejection fraction in patients undergoing coronary artery bypass grafting (CABG) are limited and i

121 The long-term outcomes of off-pump coronary artery bypass grafting (CABG) are the subject o

122 nd MV replacement and repair with or without coronary artery bypass grafting (CABG) between 2007 and

123 coronary syndromes (ACS) undergoing isolated coronary artery bypass grafting (CABG) compared with asp

124 telet therapy (DAPT) in patients who undergo coronary artery bypass grafting (CABG) following acute c

125 h left main coronary artery (LMCA) stenosis, coronary artery bypass grafting (CABG) has been the stan

126 mited data regarding long-term results after coronary artery bypass grafting (CABG) in young adults.

127 enosis of saphenous vein grafts (SVGs) after coronary artery bypass grafting (CABG) is common and oft

128 Coronary artery bypass grafting (CABG) is the standard t

129 Patients undergoing coronary artery bypass grafting (CABG) must often see mu

130 It is unknown if coronary artery bypass grafting (CABG) or percutaneous c

131 unclear whether revascularization by either coronary artery bypass grafting (CABG) or percutaneous c

132 Today's coronary artery bypass grafting (CABG) population appear

133 d data on outcomes of patients with previous coronary artery bypass grafting (CABG) presenting with S

134 icated in stroke risk at the time of on-pump coronary artery bypass grafting (CABG) procedures.

135 Coronary artery bypass grafting (CABG) remains the stand

136 Current guidelines suggest that coronary artery bypass grafting (CABG) should be the pre

137 omized trial data support the superiority of coronary artery bypass grafting (CABG) surgery over perc

138 al, 33 patients who were undergoing off-pump coronary artery bypass grafting (CABG) were randomly ass

139 ailure) trial compared a strategy of routine coronary artery bypass grafting (CABG) with guideline-ba

140 th from randomized trials that have compared coronary artery bypass grafting (CABG) with percutaneous

141 percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), on long-term out

142 cular (LV) biopsies from patients undergoing coronary artery bypass grafting (CABG), only the activat

143 t alone, percutaneous coronary intervention, coronary artery bypass grafting (CABG), or CABG plus mit

144 In coronary artery bypass grafting (CABG), the combined use

145 ent literature on standardization of care in coronary artery bypass grafting (CABG), with particular

146 nd with a higher risk of complications after coronary artery bypass grafting (CABG).

147 an increased risk of adverse outcomes after coronary artery bypass grafting (CABG).

148 predict cardiovascular events or death after coronary artery bypass grafting (CABG).

149 cutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG).

150 percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).

151 s may present an alternative to conventional coronary artery bypass grafting (CABG).

152 levation acute coronary syndromes undergoing coronary artery bypass grafting (CABG).

153 percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG); a small percenta

154 afts intraoperatively in patients undergoing coronary artery bypass grafting (CABG); however, studies

155 inically significant bleeding not related to coronary artery bypass grafting (CABG; major, minor, or

156 CABG from the European Multicenter Study on Coronary Artery Bypass Grafting (E-CABG) registry betwee

157 0.64; 95% confidence interval, 0.60-0.69) or coronary artery bypass grafting (hazard ratio, 0.53; 95%

158 -main disease who underwent primary isolated coronary artery bypass grafting (MAG, n = 5580; LITA+SVG

159 ies undergoing colectomy, lung resection, or coronary artery bypass grafting (n = 1,033,255) to creat

160 onfidence interval, 1.02-1.19) and emergency coronary artery bypass grafting (odds ratio, 1.32; 95% c

161 Aortic atheroma (TAVI) and concomitant coronary artery bypass grafting (SAVR) are independent r

162 ty of Thoracic Surgeons composite rating for coronary artery bypass grafting (STS-CABG), and Centers

163 echocardiography), coronary angiography, or coronary artery bypass grafting (without angiography) as

164 on adjusted OR: 0.74; 95% CI: 0.73 to 0.75) (coronary artery bypass grafting adjusted OR: 0.61; 95% C

165 cic Surgeons records; 162 572 (61%) isolated coronary artery bypass grafting admissions constituted t

166 no clear guidelines on the use of the RA in coronary artery bypass grafting after its catheterizatio

167 needed to risk stratify patients undergoing coronary artery bypass grafting and identify candidates

168 Two cohorts of patients who underwent coronary artery bypass grafting and received perioperati

169 In-hospital coronary artery bypass grafting and renal insufficiency

170 cribes 20-year results of RA grafts used for coronary artery bypass grafting and the effects of RA re

171 Of 10 633 adults who underwent coronary artery bypass grafting and valve surgery betwee

172 fibrillation (AF) in patients who underwent coronary artery bypass grafting and were treated with pe

173 Patients having coronary artery bypass grafting and/or cardiac valve rep

174 These findings may help guide post-coronary artery bypass grafting antiplatelet therapy.

175 sion of native coronary artery disease after coronary artery bypass grafting are unknown.

176 s should be maximized in patients undergoing coronary artery bypass grafting because they have excell

177 ld have on previously cannulated RAs used as coronary artery bypass grafting conduits.

178 e., no percutaneous coronary intervention or coronary artery bypass grafting during the index hospita

179 A total of 508 patients who underwent coronary artery bypass grafting for cardiogenic shock co

180 ndomized controlled trial comparing HCR with coronary artery bypass grafting has recently emerged in

181 ternal mammary artery (BIMA) conduits during coronary artery bypass grafting have better long-term su

182 Nearly 50% of patients undergoing coronary artery bypass grafting have diabetes.

183 d national Medicare beneficiaries undergoing coronary artery bypass grafting in 2008 to 2010 (N = 255

184 ns about competitive flow and the benefit of coronary artery bypass grafting in intermediate LAD sten

185 ial infarction is an indication for emergent coronary artery bypass grafting in patients not amenable

186 antly higher risk of mortality and emergency coronary artery bypass grafting in patients treated by n

187 Emergency coronary artery bypass grafting in patients with acute m

188 ader spectrum of patients who are undergoing coronary artery bypass grafting in routine practice.

189 n, and percutaneous coronary intervention or coronary artery bypass grafting in the preceding 12 mont

190 of a third arterial conduit in patients with coronary artery bypass grafting is not associated with h

191 n (HCR) combines minimally invasive surgical coronary artery bypass grafting of the left anterior des

192 d follow-up angiography 12 to 18 months post-coronary artery bypass grafting or earlier clinically dr

193 erences in coronary revascularization rates (coronary artery bypass grafting or percutaneous coronary

194 ied, having a primary diagnosis of emergency coronary artery bypass grafting or valve replacement, an

195 issions Reduction Program formula using only coronary artery bypass grafting readmissions with a 3% m

196 Coronary artery bypass grafting remains one of the most

197 conduit improves outcomes after multivessel coronary artery bypass grafting remains unclear.

198 Coronary artery bypass grafting seems to be the preferre

199 Coronary artery bypass grafting success is limited by ve

200 retrospective analysis of 47 984 consecutive coronary artery bypass grafting surgeries performed from

201 Among the study population, 1482 coronary artery bypass grafting surgeries with BIMA were

202 analyzed 20 896 patients undergoing isolated coronary artery bypass grafting surgery at 33 medical ce

203 rs of 30-day all-cause readmission following coronary artery bypass grafting surgery by using nationa

204 A coronary artery bypass grafting surgery readmission meas

205 Seventy patients undergoing coronary artery bypass grafting underwent an echocardiog

206 We randomly assigned 304 patients undergoing coronary artery bypass grafting using BITA to either in

207 1); high-performing programs had higher mean coronary artery bypass grafting volumes (n = 241) than a

208 c reporting sites had higher mean annualized coronary artery bypass grafting volumes than nonreportin

209 , patient-level mortality rates for isolated coronary artery bypass grafting were consistently lower

210 ndomized clinical trial, patients undergoing coronary artery bypass grafting with an internal mammary

211 th low ejection fraction who were undergoing coronary artery bypass grafting with cardiopulmonary byp

212 o 40% and scheduled for isolated or combined coronary artery bypass grafting with cardiopulmonary byp

213 who underwent primary, isolated multivessel coronary artery bypass grafting with the left internal t

214 studies comparing the long-term outcomes of coronary artery bypass grafting with the use of 2-arteri

215 tus by percutaneous coronary intervention or coronary artery bypass grafting within 7 days of the ind

216 with multivessel disease who are undergoing coronary artery bypass grafting without increased mortal

217 procedures (stress imaging, angiography, or coronary artery bypass grafting) after the index PCI wer

218 At 12 to 18 months post-coronary artery bypass grafting, 782 of 1828 (42.8%) pat

219 scharged after 10 major surgical procedures (coronary artery bypass grafting, abdominal aortic aneury

220 primary percutaneous coronary intervention, coronary artery bypass grafting, and medical therapy, re

221 l artery (RA) is a commonly used conduit for coronary artery bypass grafting, and recent studies have

222 jury in percutaneous coronary interventions, coronary artery bypass grafting, and reperfused acute my

223 ubgroup analysis of patients undergoing only coronary artery bypass grafting, and results were simila

224 impact on the function of RA grafts used in coronary artery bypass grafting, and there is now compre

225 atinine clearance <60 mL/min, treatment with coronary artery bypass grafting, anemia, and diabetes me

226 beneficiaries aged 65 to 99 years undergoing coronary artery bypass grafting, aortic valve repair, or

227 uch that patients with low CFR who underwent coronary artery bypass grafting, but not percutaneous co

228 lve replacement and aortic valve replacement+coronary artery bypass grafting, extensive updating usin

229 In patients undergoing coronary artery bypass grafting, genetic variation in GR

230 previous cerebrovascular event, in-hospital coronary artery bypass grafting, in-hospital bleeding, a

231 y alone, percutaneous coronary intervention, coronary artery bypass grafting, or more information req

232 nditions, and in-hospital procedures such as coronary artery bypass grafting, percutaneous coronary i

233 We identified patients who underwent coronary artery bypass grafting, pulmonary lobectomy, en

234 30-day readmissions for patients undergoing coronary artery bypass grafting, pulmonary lobectomy, en

235 ) between CFR and early revascularization by coronary artery bypass grafting, such that patients with

236 Following coronary artery bypass grafting, there is a massive incr

237 f 283,131 patients who were readmitted after coronary artery bypass grafting, to 142,142 (83.2%) of 1

238 Patients had a mix of coronary artery bypass grafting, valve surgery, and comb

239 Secondary end points included emergency coronary artery bypass grafting, vascular complications,

240 scending (LAD) artery in patients undergoing coronary artery bypass grafting.

241 m were obtained from 306 patients undergoing coronary artery bypass grafting.

242 rone that was similar to patients undergoing coronary artery bypass grafting.

243 .0% of patients and were most frequent after coronary artery bypass grafting.

244 nosis (AS) who underwent AVR with or without coronary artery bypass grafting.

245 e atrial fibrillation (PoAF) is common after coronary artery bypass grafting.

246 native coronary artery disease 1 year after coronary artery bypass grafting.

247 rel or aspirin plus placebo for 1 year after coronary artery bypass grafting.

248 ary intervention, and 2832 (10.7%) underwent coronary artery bypass grafting.

249 , 57,961 patients underwent primary isolated coronary artery bypass grafting.

250 of 2 arterial grafts in patients undergoing coronary artery bypass grafting.

251 this contributes to clinical outcomes after coronary artery bypass grafting.

252 should be considered more frequently during coronary artery bypass grafting.

253 ions, contemporary practice, and outcomes of coronary artery bypass grafting.

254 improve short- and long-term outcomes after coronary artery bypass grafting.

255 ion, percutaneous coronary intervention, and coronary artery bypass grafting.

256 and improved survival in patients undergoing coronary artery bypass grafting.

257 rcutaneous coronary intervention: 28 011 and coronary artery bypass grafting: 6277).

258 ade: r=0.46; P=0.0001) and SAVR (concomitant coronary artery bypass grafting: r=-0.33; P=0.03).

259 The survival benefit of a strategy of coronary-artery bypass grafting (CABG) added to guidelin

260 In a trial comparing coronary-artery bypass grafting (CABG) alone with CABG p

261 he benefits of adding mitral-valve repair to coronary-artery bypass grafting (CABG) are uncertain.

262 ral internal thoracic (mammary) arteries for coronary-artery bypass grafting (CABG) may improve long-

263 Coronary-artery bypass grafting (CABG) surgery may be pe

264 s have shown lower long-term mortality after coronary-artery bypass grafting (CABG) than after percut

265 nary artery disease are usually treated with coronary-artery bypass grafting (CABG).

266 ronary chronic total occlusions (CTOs) after coronary artery bypass grafts (CABGs) is higher than in

267 This included 10 coronary artery bypass grafts, 2 epicardial implantable

268 cardiac surgery, especially the presence of coronary artery bypass grafts, is thought to preclude pe

269 nts with previous cardiac surgery, including coronary artery bypass grafts.

270 was achieved in 6 of 10 patients with prior coronary artery bypass grafts.

271 utaneous coronary intervention (28%), urgent coronary artery bypass surgery (27.5%), maternal mortali

272 rovide recommendations for optimal timing of coronary artery bypass surgery (CABG) in patients with n

273 directly compared the incidence of AKI after coronary artery bypass surgery (CABG) or after percutane

274 s coronary intervention (PCI) With Taxus and coronary artery bypass surgery (CABG)] score is a decisi

275 ry revascularization (HCR) combines arterial coronary artery bypass surgery (most commonly minimally

276 y intervention in patients with a history of coronary artery bypass surgery (PCI-CABG) is limited and

277 Both coronary artery bypass surgery and percutaneous interven

278 lacks and 136,362 whites undergoing isolated coronary artery bypass surgery at 663 Society of Thoraci

279 The EXCEL (Evaluation of Xience Versus Coronary Artery Bypass Surgery for Effectiveness of Left

280 high SYNTAX (TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narr

281 (TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narr

282 have reported that black patients undergoing coronary artery bypass surgery had worse outcomes than w

283 te and high likelihood of complications, and coronary artery bypass surgery is often required.

284 rhythm was performed in 185 patients during coronary artery bypass surgery of whom 13 had a history

285 Coronary artery bypass surgery was performed in 44 cases

286 of procedural mortality and morbidity after coronary artery bypass surgery were higher among black p

287 Relative to whites, blacks undergoing coronary artery bypass surgery were younger, yet had hig

288 2% (percutaneous coronary intervention, 32%; coronary artery bypass surgery, 10%).

289 5% (percutaneous coronary intervention, 38%; coronary artery bypass surgery, 7%).

290 After excluding patients with prior coronary artery bypass surgery, 925 patients were includ

291 the readmitted patients, 13% had PCI, 2% had coronary artery bypass surgery, and 3% died during the r

292 se of previously cannulated RAs as grafts in coronary artery bypass surgery, and there are no clear g

293 We included eligible PCI, coronary artery bypass surgery, and valve surgery patien

294 n cardiac rehabilitation referral after PCI, coronary artery bypass surgery, and valve surgery.

295 eripheral vascular disease, absence of prior coronary artery bypass surgery, angina, low body mass in

296 inal arterial bypass, aortobifemoral bypass, coronary artery bypass surgery, oesophagectomy, colectom

297 ng percutaneous coronary intervention (PCI), coronary artery bypass surgery, or valve surgery be refe

298 oke, percutaneous coronary intervention, and coronary artery bypass surgery.

299 , and in 51% of patients undergoing a priori coronary artery bypass surgery.

300 d undergone cardiothoracic surgery, of which coronary artery bypass, valvular repair, and pulmonary t